Shiyi Wang

Shiyi Wang is a Bioinformatics Scientist I at Scribe Therapeutics since February 2024, with prior experience as a PhD student at the University of Washington from September 2020 to December 2023, where significant work included modeling HIV evolution during clinical therapy failures. Before this, Shiyi Wang conducted research at Scripps Research from August 2018 to August 2020, focusing on HIV evolution and optimizing long-read sequencing methodologies. Earlier academic experiences include a role as a visiting scholar at the University of Michigan, performing research on lysosomal channel modulation. Shiyi Wang holds a PhD from the University of Washington and another from Scripps Research, alongside a Bachelor's degree from Zhejiang University.